Latest Breaking News On - Gemseki inc - Page 1 : comparemela.com

Harvard University and Kyowa Kirin enter strategic research alliance Multiyear collaboration to advance innovation in therapeutics and biomedical technology platforms Cambridge, Mass. and Tokyo, Japan – February 25/26, 2021 – Harvard University and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:4151) announce that they have entered into a strategic research alliance. The 5-year alliance, established by Harvard’s Office of Technology Development (OTD), aims to fuel scientific collaboration among academic and industry researchers to accelerate discovery and early-stage innovation in translational biomedical science. Kyowa Kirin is a Japan-based global specialty pharmaceutical company with drug discovery and commercialization capabilities focused in core therapeutic areas of nephrology, oncology, immunology and allergy, and the central nervous system. By creating opportunities for formal scientific collaboration, the alliance will leverage industry insight and drug dev

United kingdomUnited statesAsia pacificCaroline perryHiroki nakamuraSteering committeeGemseki incHarvard university office of technology developmentA global specialty pharmaceutical companyHarvard universitySciences engineering acceleratorHarvard office of technology developmentKyowa kirin co ltdRd division of kyowa kirinKyowa kirinTechnology development